Bank Of New York Mellon Corp Replimune Group, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $2.86 Million - $4.68 Million	167,569 New	167,569 $4.56 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $650,020 - $881,278	41,668 Added 39.72%	146,562 $2.53 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $55,704 - $83,556	-4,182 Reduced 3.83%	104,894 $1.83 Million
Q1 2022 May 11, 2022	SELL	$15.24 - $29.75 $6,187 - $12,078	-406 Reduced 0.37%	109,076 $1.85 Million
Q4 2021 Feb 11, 2022	BUY	$25.43 - $34.25 $440,269 - $592,970	17,313 Added 18.78%	109,482 $2.97 Million
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $400,938 - $547,035	13,835 Added 17.66%	92,169 $2.73 Million
Q2 2021 Aug 11, 2021	SELL	$28.5 - $39.37 $247,494 - $341,889	-8,684 Reduced 9.98%	78,334 $3.01 Million
Q1 2021 May 13, 2021	SELL	$30.22 - $45.57 $30,068 - $45,342	-995 Reduced 1.13%	87,018 $2.65 Million
Q4 2020 Feb 09, 2021	BUY	$23.5 - $52.65 $579,533 - $1.3 Million	24,661 Added 38.93%	88,013 $3.36 Million
Q3 2020 Nov 12, 2020	BUY	$18.85 - $27.0 $261,336 - $374,328	13,864 Added 28.01%	63,352 $1.46 Million
Q2 2020 Aug 12, 2020	BUY	$9.76 - $25.95 $151,894 - $403,859	15,563 Added 45.87%	49,488 $1.23 Million
Q1 2020 May 06, 2020	BUY	$8.9 - $19.08 $18,885 - $40,487	2,122 Added 6.67%	33,925 $338,000
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $36,176 - $53,626	3,116 Added 10.86%	31,803 $456,000
Q3 2019 Nov 07, 2019	SELL	$10.01 - $16.87 $11,841 - $19,957	-1,183 Reduced 3.96%	28,687 $398,000
Q2 2019 Aug 12, 2019	SELL	$12.51 - $17.28 $4,528 - $6,255	-362 Reduced 1.2%	29,870 $438,000
Q1 2019 May 14, 2019	BUY	$10.26 - $16.24 $63,437 - $100,411	6,183 Added 25.71%	30,232 $460,000
Q4 2018 Feb 11, 2019	BUY	$9.97 - $15.57 $41,963 - $65,534	4,209 Added 21.21%	24,049 $240,000
Q3 2018 Nov 09, 2018	BUY	$14.99 - $22.14 $297,401 - $439,257	19,840 New	19,840 $0

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$155 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$139 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$68.4 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$67.2 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$66.2 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account